# ZITUVIMET

NDC: 70771-1860
Generic name: Sitagliptin and Metformin Hydrochloride
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20240314

FDA application: NDA216743

## Active ingredients

- METFORMIN HYDROCHLORIDE: 1000 mg/1
- SITAGLIPTIN: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1860"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1860
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0098dec4-f0e5-45d5-8aa4-5d0faf9ab142